opsens at europcr 2022, how to manage patients with cad and aortic stenoses? the prime class study
Published 2 years ago • 218 plays • Length 9:17Download video MP4
Download video MP3
Similar videos
-
9:16
how to manage patients with coronary artery disease and aortic stenosis? the prime class study
-
54:59
double jeopardy: coronary disease in patients undergoing tavi - europcr 2022
-
49:46
angiography-derived physiological assessment of coronary artery stenosis severity - europcr 2022
-
44:00
the challenge of the diabetic patient with diffuse coronary artery disease - europcr 2022
-
59:28
the role of coronary interventionalist in tavi - from referral to timing of pci - europcr 2022
-
44:19
stemi: is opsens optowire iii a game-changer in complete revascularization? - europcr 2021
-
48:18
pressure microcatheter guided pci: optimise stent implantation and assess functional result
-
30:31
coronary artery disease and heart failure (nadia fida, md) july 8, 2020
-
58:43
pci in calcified left main stenosis: tools for a safe and predictable outcome - europcr 2022
-
59:21
breaking the calcium ceiling in bifurcation stenoses with contemporary pci - europcr 2023
-
5:45
hemodynamics and minimalist tavi - how does it fit? - europcr 2022
-
45:56
importance of extensive revascularisation and timing of mcs - europcr 2021
-
1:30:25
how should i treat a patient with severe aortic stenosis and heavily calcified cad?
-
14:24
timing and indication for pci in tavi patients with coronary disease
-
23:53
cad – coronary artery disease pathway
-
6:59
asymptomatic severe aortic stenosis, how will new evidence change our practice? europcr 2024
-
58:25
lifetime patient management and the importance of tavr hemodynamics: tct 2022
-
44:46
the cathlab of the future - europcr 2022